ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,821 | -94.1% | 158,464 | -76.9% | 0.00% | – |
| Q2 2023 | $350,350 | -26.1% | 686,961 | -8.8% | 0.00% | – |
| Q1 2023 | $474,294 | +2.8% | 752,848 | +6.0% | 0.00% | – |
| Q4 2022 | $461,384 | -85.5% | 710,497 | -61.6% | 0.00% | -100.0% |
| Q3 2022 | $3,185,000 | +87.4% | 1,851,942 | +35.1% | 0.00% | – |
| Q2 2022 | $1,700,000 | +345.0% | 1,370,802 | +133.3% | 0.00% | – |
| Q1 2022 | $382,000 | -85.8% | 587,500 | -76.2% | 0.00% | – |
| Q4 2021 | $2,694,000 | -13.3% | 2,472,508 | +44.7% | 0.00% | – |
| Q3 2021 | $3,108,000 | -28.0% | 1,708,170 | +4.4% | 0.00% | – |
| Q2 2021 | $4,318,000 | -2.7% | 1,635,808 | +32.7% | 0.00% | – |
| Q1 2021 | $4,438,000 | -52.7% | 1,232,936 | -66.9% | 0.00% | – |
| Q4 2020 | $9,390,000 | +90.4% | 3,726,210 | +90.3% | 0.00% | -100.0% |
| Q3 2020 | $4,933,000 | -27.0% | 1,957,789 | -5.0% | 0.00% | 0.0% |
| Q2 2020 | $6,759,000 | +5.1% | 2,060,467 | -21.5% | 0.00% | -66.7% |
| Q1 2020 | $6,431,000 | -57.7% | 2,624,997 | -18.5% | 0.00% | -25.0% |
| Q4 2019 | $15,199,000 | +69.3% | 3,220,070 | +53.5% | 0.00% | 0.0% |
| Q3 2019 | $8,978,000 | -79.8% | 2,097,870 | -72.4% | 0.00% | -33.3% |
| Q2 2019 | $44,377,000 | +408.4% | 7,611,955 | +235.7% | 0.01% | +50.0% |
| Q1 2019 | $8,729,000 | +143.5% | 2,267,398 | +18.3% | 0.00% | +300.0% |
| Q4 2018 | $3,585,000 | +15.5% | 1,917,274 | +97.7% | 0.00% | 0.0% |
| Q3 2018 | $3,103,000 | -15.3% | 969,741 | -20.1% | 0.00% | 0.0% |
| Q2 2018 | $3,664,000 | -30.6% | 1,213,178 | -9.9% | 0.00% | 0.0% |
| Q1 2018 | $5,276,000 | -49.6% | 1,345,823 | -46.8% | 0.00% | -66.7% |
| Q4 2017 | $10,464,000 | -72.6% | 2,527,690 | -59.3% | 0.00% | -80.0% |
| Q3 2017 | $38,160,000 | -32.6% | 6,214,860 | -31.7% | 0.02% | -40.0% |
| Q2 2017 | $56,634,000 | +245.3% | 9,105,078 | +252.0% | 0.02% | +212.5% |
| Q1 2017 | $16,401,000 | -28.1% | 2,586,870 | -39.3% | 0.01% | -27.3% |
| Q4 2016 | $22,819,000 | -6.3% | 4,265,187 | -1.4% | 0.01% | -8.3% |
| Q3 2016 | $24,358,000 | +17.5% | 4,326,314 | +14.6% | 0.01% | 0.0% |
| Q2 2016 | $20,728,000 | -32.3% | 3,775,630 | -8.5% | 0.01% | -25.0% |
| Q1 2016 | $30,622,000 | -40.9% | 4,126,861 | -33.8% | 0.02% | -30.4% |
| Q4 2015 | $51,783,000 | +22.9% | 6,231,342 | +33.3% | 0.02% | +21.1% |
| Q3 2015 | $42,129,000 | +1.4% | 4,675,757 | +35.0% | 0.02% | +5.6% |
| Q2 2015 | $41,562,000 | +49.3% | 3,463,548 | +34.0% | 0.02% | +38.5% |
| Q1 2015 | $27,843,000 | +176.9% | 2,585,208 | +30.4% | 0.01% | +225.0% |
| Q4 2014 | $10,054,000 | +107.0% | 1,983,054 | +7.8% | 0.00% | +33.3% |
| Q3 2014 | $4,857,000 | -30.8% | 1,839,951 | +5.7% | 0.00% | 0.0% |
| Q2 2014 | $7,015,000 | +37.4% | 1,740,751 | +56.2% | 0.00% | 0.0% |
| Q1 2014 | $5,106,000 | -54.4% | 1,114,789 | -56.7% | 0.00% | -25.0% |
| Q4 2013 | $11,186,000 | +113.8% | 2,577,315 | +94.6% | 0.00% | +100.0% |
| Q3 2013 | $5,232,000 | +50.4% | 1,324,379 | -19.8% | 0.00% | -33.3% |
| Q2 2013 | $3,478,000 | – | 1,651,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
| MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
| MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
| CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
| Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
| Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
| MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
| Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
| ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
| Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |